Articles with public access mandates - Harini NivarthiLearn more
Not available anywhere: 2
Interplay of transcription factors STAT3, STAT1 and AP-1 mediates activity of the matrix metallo-proteinase-1 promoter in colorectal carcinoma cells.
KH FRIEDRICH, A MÜLLER, J GASCH, KF ALBRING, F ABERGER, ...
Neoplasma 66 (3), 2019
Mandates: Federal Ministry of Education and Research, Germany
Stat5 as a hematopoietic master regulator for differentiation and neoplasia development
H Nivarthi, K Friedbichler, R Moriggl
Jak-Stat Signaling: From Basics to Disease, 153-167, 2012
Mandates: Austrian Science Fund
Available somewhere: 21
Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants
I Chachoua, C Pecquet, M El-Khoury, H Nivarthi, RI Albu, C Marty, ...
Blood, The Journal of the American Society of Hematology 127 (10), 1325-1335, 2016
Mandates: Austrian Science Fund, National Fund for Scientific Research, Belgium …
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms
JD Milosevic Feenstra, H Nivarthi, H Gisslinger, E Leroy, E Rumi, ...
Blood, The Journal of the American Society of Hematology 127 (3), 325-332, 2016
Mandates: Austrian Science Fund, National Fund for Scientific Research, Belgium …
Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis
C Marty, C Pecquet, H Nivarthi, M El-Khoury, I Chachoua, M Tulliez, ...
Blood, The Journal of the American Society of Hematology 127 (10), 1317-1324, 2016
Mandates: Austrian Science Fund, National Fund for Scientific Research, Belgium …
Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer
D Unterleuthner, P Neuhold, K Schwarz, L Janker, B Neuditschko, ...
Angiogenesis 23, 159-177, 2020
Mandates: Austrian Science Fund
Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis
B Grabner, D Schramek, KM Mueller, HP Moll, J Svinka, T Hoffmann, ...
Nature communications 6 (1), 6285, 2015
Mandates: Austrian Science Fund
Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression
N Kramer, J Schmöllerl, C Unger, H Nivarthi, A Rudisch, D Unterleuthner, ...
Oncogene 36 (39), 5460-5472, 2017
Mandates: US National Institutes of Health, Austrian Science Fund
STAT5BN642H is a driver mutation for T cell neoplasia
HTT Pham, B Maurer, M Prchal-Murphy, R Grausenburger, ...
The Journal of clinical investigation 128 (1), 387-401, 2018
Mandates: Austrian Science Fund, German Research Foundation, European Commission
Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants
C Pecquet, I Chachoua, A Roy, T Balligand, G Vertenoeil, E Leroy, ...
Blood, The Journal of the American Society of Hematology 133 (25), 2669-2681, 2019
Mandates: Austrian Science Fund, National Fund for Scientific Research, Belgium …
Thrombopoietin receptor is required for the oncogenic function of CALR mutants
H Nivarthi, D Chen, C Cleary, B Kubesova, R Jäger, E Bogner, C Marty, ...
Leukemia 30 (8), 1759-1763, 2016
Mandates: Austrian Science Fund
Activated STAT5 confers resistance to intestinal injury by increasing intestinal stem cell proliferation and regeneration
S Gilbert, H Nivarthi, CN Mayhew, YH Lo, TK Noah, J Vallance, T Rülicke, ...
Stem cell reports 4 (2), 209-225, 2015
Mandates: US National Institutes of Health, Austrian Science Fund
Pathologic activation of thrombopoietin receptor and JAK2-STAT5 pathway by frameshift mutants of mouse calreticulin
T Balligand, Y Achouri, C Pecquet, I Chachoua, H Nivarthi, C Marty, ...
Leukemia 30 (8), 1775-1778, 2016
Mandates: Austrian Science Fund, National Fund for Scientific Research, Belgium …
High activation of STAT5A drives peripheral T-cell lymphoma and leukemia
B Maurer, H Nivarthi, B Wingelhofer, HTT Pham, M Schlederer, T Suske, ...
Haematologica 105 (2), 435, 2020
Mandates: Austrian Science Fund
The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth
H Nivarthi, C Gordziel, M Themanns, N Kramer, M Eberl, B Rabe, ...
Oncotarget 7 (32), 51096, 2016
Mandates: US National Institutes of Health, Austrian Science Fund, European Commission
CDK6 coordinates JAK2V617F mutant MPN via NF-κB and apoptotic networks
IZ Uras, B Maurer, H Nivarthi, P Jodl, K Kollmann, M Prchal-Murphy, ...
Blood, The Journal of the American Society of Hematology 133 (15), 1677-1690, 2019
Mandates: Austrian Science Fund, European Commission
RETRACTED ARTICLE: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation
T Javaheri, Z Kazemi, J Pencik, HTT Pham, M Kauer, R Noorizadeh, ...
Cell death & disease 7 (10), e2419-e2419, 2016
Mandates: Austrian Science Fund, German Research Foundation, UK Medical Research …
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms
C Pecquet, N Papadopoulos, T Balligand, I Chachoua, A Tisserand, ...
Blood 141 (8), 917-929, 2023
Mandates: Austrian Science Fund, National Fund for Scientific Research, Belgium …
STAT5 is Expressed in CD34+/CD38− Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms
E Hadzijusufovic, A Keller, D Berger, G Greiner, B Wingelhofer, ...
Cancers 12 (4), 1021, 2020
Mandates: Austrian Science Fund
Stat5 gene dosage in T cells modulates CD8+ T‐cell homeostasis and attenuates contact hypersensitivity response in mice
H Nivarthi, M Prchal‐Murphy, A Swoboda, M Hager, M Schlederer, ...
Allergy 70 (1), 67-79, 2015
Mandates: Austrian Science Fund
Publication and funding information is determined automatically by a computer program